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Introduction: The aim of this study was to objectively assess time spent in physical
activity (PA) and sedentary behavior (SB) in patients with schizophrenia compared to
healthy controls matched for age, gender and socioeconomic status. Associations
between both PA and cardiorespiratory fitness (CRF) and mental and physical health
parameters in patients with schizophrenia were examined.
Materials and Methods: Moderate and vigorous PA (MVPA), moderate PA, vigorous
PA, total and active energy expenditure (TEE and AEE), number of steps, lying down
and sleeping time was assessed with SenseWear Pro-2 body monitoring system for
three 24-h bouts in patients with schizophrenia (n = 63) and matched healthy controls
(n= 55). Severity of symptoms (Positive and Negative Syndrome Scale and Montgomery
and Åsberg Depression Rating Scale), CRF (peak oxygen uptake, VO2peak), body mass
index (BMI), and metabolic syndrome were assessed.
Results: Patients with schizophrenia performed less MVPA and moderate activity had
lower TEE and AEE, spent more time per day lying down and sleeping, and had poorer
CRF compared to healthy controls. The amount of MVPA, but especially CRF was
associated with severity of negative symptoms in patients with schizophrenia. Only CRF
was associated with BMI.
Discussion: The current data offer further evidence for interventions aiming to increase
physical activity and decrease sedentary behavior. Given strong associations of CRF with
both negative symptoms and BMI, treatment aimed at CRF-improvement may prove to
be effective.
Keywords: physical activity, sedentary behavior, cardiorespiratory fitness, schizophrenia, matched
healthy controls
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INTRODUCTION
The premature mortality risk in patients with schizophrenia is
two to three times higher compared to the general population
leading to a 7–20 year reduction in life expectancy (1–3), mainly
due to cardiovascular disease (4, 5). The increased cardio-
metabolic risk is partly attributable to side effects of antipsychotic
medication such as weight gain, dyslipidemia, and diabetes
mellitus (4, 6).
Three recent meta-analyses show patients with schizophrenia
engage in less physical activity (PA) (7), have high levels of
sedentary behavior (SB) in their waking day (8), and have
low cardiorespiratory fitness (CRF)-levels (9). The majority
of the included studies used self-report to assess PA (7)
which, due to recall errors and social desirability bias, has
limited validity (10, 11). Illustrative, whereas no difference in
PA was found using self-report measurement, accelerometry
showed a large reduction of PA in patients with schizophrenia
compared to healthy controls (12). As for SB, a meta-analysis
demonstrated that patients with psychosis spend 11 h of their
waking day being sedentary. Again, objective measurement of
SB demonstrated significantly higher levels of SB compared to
self-report measurements (8).
In patients with psychosis, a limited number of studies
have suggested that high levels of SB and low levels of PA
are associated with an increased cardio-metabolic risk [e.g.,
(13, 14)]. These studies did not take CRF into account, and
most of these studies assessed SB and PA using self-report
(10, 11). One study examined independent associations of
objectively measured SB and PA with cardio-metabolic risk
in inpatients with schizophrenia as well as in age/sex/body
mass index-matched healthy controls (15), but failed to take
CRF into account. As far as we know, only one study (16)
did include CRF when investigating associations between SB
and PA with cardio-metabolic risk factors in patients with
psychosis. This study showed that SB is, independently of PA
and CRF, associated with the individual risk factors waist and
fasting blood glucose. Strikingly, CRF, even when controlled
for SB and PA, remained significantly associated with clustered
cardio-metabolic risk and the individual risk factor waist. The
study by Bueno-Antequera et al. (16) is mildly hampered by
some limitations. For instance, they did not include healthy
controls, measured CRF with a submaximal test instead of
a “gold standard” cardiopulmonary exercise testing (CPET),
thus limiting the validity of its results (17), and had a small
sample of size of outpatients, predominantly men. Therefore,
they call for more research, as well as the use of (gold standard)
objective measures.
The aim of this study, therefore, is to compare objectively
assessed SB and PA, as well as CRF measured by CPET, in
patients with schizophrenia with matched, physically inactive,
but otherwise healthy controls using data from the “The
Outcome of Psychosis and Fitness Therapy” study (TOPFIT).
The second aim was to determine whether SB, PA,
and CRF were associated with mental and physical health




This study included data of 63 patients with a schizophrenia
spectrum disorder and 55 healthy controls, matched for
gender, age, and socioeconomic status (expressed as the
highest educational level of one of the parents). Patients were
recruited at the University Medical Center Utrecht (Netherlands)
(n = 26) and regional mental health care institutes (Altrecht;
GGZ Duin- en Bollenstreek; GGZ Friesland) (n = 37).
Healthy controls (n = 55) were recruited from the local
population via advertisements. Participants were enrolled in
the study between May 2007 and May 2010 and written
informed consent was obtained after the procedures, and
possible side effects were explained. This study was part of
the TOPFIT project (“The Outcome of Psychosis and Fitness
Therapy”) and registered in the ISRCTN register (http://
www.controlled-trials.com/ISRCTN46241817). Patients had a
diagnosis of schizophrenia (n = 45), schizoaffective (n = 15),
or schizophreniform disorder (n = 3) according to the
Diagnostic and Statistical Manual of Mental Disorders, fourth
edition (DSM-IV). Diagnosis was confirmed by psychiatrists
using the Comprehensive Assessment of Schizophrenia and
History (CASH) (18). Patients were stable on antipsychotic
medication, i.e., using the same dosage for at least 4 weeks
prior to inclusion. They showed no evidence for significant
cardiovascular, neuromuscular, endocrine or other somatic
disorders that prevented safe participation in the study (19).
Patients had no primary diagnosis of alcohol or substance abuse
and had an IQ ≥ 70, as measured with the Wechsler Adult
Intelligence Scale Short Form (WAIS-III SF) (20).
The inclusion criteria for the healthy controls were no
diagnosis of psychiatric disorders according to DSM-IV lifetime,
no first-degree relative with a psychotic or depressive disorder,
and being physically inactive before inclusion (i.e., undertaking
<1 h of moderate PA weekly; based on self-report). The
study was approved by the Human Ethics Committee of the
University Medical Center Utrecht and research committees of
participating centers.
Assessments
All measurements were assessed by a research assistant and a
sports physician. Participants were asked to wear the SenseWear
Pro-2 (BodyMedia, Inc., Pittsburgh, PA), body monitoring
system during three 24-h time bouts (2 weekdays and 1
weekend day) except during water-based activities. This device
objectively measures PA and estimates energy expenditure (21–
23). The SenseWear was worn over the right arm triceps
muscle and assesses minute-to-minute data through multiple
sensors, namely a two-axis accelerometer and sensors measuring
heat flux, galvanic skin and near body-temperature. Data
are combined with gender, age, body weight, and height, to
measures physical (in)activity and estimate energy expenditure
using algorithms developed by the manufacturer (SenseWear
Professional software, version 5.1.0.1289).
Several variables were calculated from the SenseWear data.
PA was expressed in average metabolic equivalents (MET; in
Frontiers in Psychiatry | www.frontiersin.org 2 February 2019 | Volume 10 | Article 87
Scheewe et al. Physical Activity and Fitness in Schizophrenia
kcal/kg/h), an indicator of daily energy expenditure. The unit
MET was used to estimate the amount of oxygen used by the
body during SB and PA. Daily average time spend in total SB (<3
MET), moderate and vigorous PA (MVPA) (≥3MET), moderate
(3–6MET), vigorous (≥6MET) were calculated from all minutes
with a MET-value. Total energy expenditure (TEE; in kcals),
active energy expenditure (AEE; in kcals: ≥3 MET), number of
steps, lying down and sleeping time were also estimated. Data was
accepted when the average on-body measuring time was at least
1,368min per day (95% of a 24-h bout).
CRF, defined as the ability of the circulatory and respiratory
systems to supply oxygen to skeletal muscles during sustained
physical activity, was assessed with a cardiopulmonary exercise
test (CPET), performed using a 20 watt per minute (W/min) step
wise incremental protocol to exhaustion on a cycle ergometer
(Lode Excalibur, Lode BV, Groningen, the Netherlands) (24).
CRF was defined as the highest oxygen uptake during any
30-s interval during the test (VO2peak ml·kg−1·min−1) (25).
Waist circumference (in cm) and anthropometric measurements
(height in cm and weight in kg), using the same calibrated
equipment in all participants, and metabolic syndrome (MetS),
assessed according to the International Diabetes Foundation
criteria (26), were obtained by the sports physician prior to
the CPET.
To evaluate the severity of schizophrenia symptoms, the
Positive and Negative Syndrome Scale (PANSS) total, positive,
negative, and general (sub)scores were assessed (27). The
Montgomery Åsberg Depression Rating Scale (MADRS) assessed
co-morbid depressive symptoms (28). Detailed information on
the amount and type of prescribed antipsychotic and other
medication were gathered. Current antipsychotic medication
prescribed was described in cumulative dosage and converted
into haloperidol equivalents, conformable to a table from the
Dutch National Health Service (29).
Statistical Analyses
SPSS 25.0 was used to analyze the data (Armonk, NY: IBMCorp).
All statistical tests were performed two-tailed and a p < 0.05
was considered significant. Data were examined for outliers.
All analyses were performed with and without extreme outliers
to examine their influence on results. In case of non-normal
distribution logarithmic transformation was applied.
Multiple analyses of variance for non-categorical variables
and χ2 analyses for categorical variables were used to
examine differences between patients with schizophrenia and
matched healthy controls in demographic and clinical variables.
Univariate analyses were used to examine differences in SB,
MVPA, moderate PA, vigorous PA, TEE, and AEE, number
of steps, lying down and sleeping time, and CRF between
patients and healthy controls. Gender, age, WAIS IQ-score,
marital status, employment status, and Body Mass Index (BMI)
were included in analyses as possible confounding factors. To
investigate if differences exist between day of measurement
(weekdays vs. weekend) within and between groups (patients vs.
controls), repeated measures analysis of variance were performed
comparing the average weekday vs. weekend day SB, MVPA,
moderate PA, vigorous PA, TEE and AEE, number of steps, lying
down, and sleeping time. Correction for multiple testing was
applied according to the Bonferroni-correction procedure.
In patients, backward linear regression analysis (criterion:
probability of F-to-remove ≥0.10) was used to assess whether
the independent variables gender, age, PANSS positive, PANSS
negative, PANSS general, employment status, and MADRS-
score were associated with the level of SB, MVPA, and
CRF (VO2peak ml·kg−1·min−1). Similarly, we examined the
association between physical health parameters (gender, age,
employment status, BMI, haloperidol equivalent of antipsychotic
medication prescribed, and number met criteria for the MetS)
and SB,MVPA, and CRF (VO2peak ml·kg−1·min−1). We repeated
the latter regression analyses in healthy controls, examining the
association between physical health parameters (gender, age,
employment status, BMI, number of met criteria for MetS) and
SB, MVPA, and CRF.
RESULTS
Descriptive Statistics
Demographic and illness characteristics are shown in Table 1.
Healthy controls had lower BMI (p = 0.01), waist circumference
(p = 0.002), triglycerides (p < 0.001), and LDL-cholesterol
(p = 0.02). Healthy controls were less likely to have MetS
(p = 0.04), met on average less MetS criteria (p = 0.003), and
smoked less cigarettes per day (p≤ 0.001). Healthy controls were
more likely married (p ≤ 0.001), had a higher IQ (p ≤ 0.001),
and higher HDL-cholesterol levels (p < 0.001). No significant
differences in demographic and illness characteristics, except
higher diastolic blood pressure (p = 0.02) and lower HDL-
cholesterol (p = 0.007), were found between male and female
patients. There were no differences in type [χ2(9) = 5.68; p= 0.77]
and dose [F(1, 58) = 1.24; p = 0.27] of antipsychotic medication
used between genders in patients.
Differences in SB, PA, and CRF
All variables, except SB, moderate PA, vigorous PA, and
active energy expenditure data, complied with normality
and homogeneity of variance demands. After logarithmic
transformation of these variables, all data were analyzed
parametrically. Average on-body percentage was below 95
percent in one patient with schizophrenia and three healthy
controls. In total, 62 patients and 52 healthy controls, with
an average on-body time of 98.3 (SD: 1.4) and 98.0 (SD: 1.2)
percent, respectively, were thus included in further analyses.
Results are presented in Table 2. Compared to physically
inactive but otherwise healthy matched controls, patients showed
significantly higher SB (p = 0.005), less MVPA (p = 0.005),
and less moderate PA (p ≤ 0.001), but equal vigorous PA
(p = 0.15). Patients with schizophrenia had significantly lower
total (p = 0.001) and active (p = 0.002) energy expenditure
compared to controls. Though the average daily number of
steps taken was lower in patients with schizophrenia (mean:
8040; SD: 3072) than in controls (mean: 8884; SD: 2837),
this difference did not reach significance (p = 0.16). Patients
spent significantly more time lying down (p ≤ 0.001) and
sleeping (p < 0.001) (expressed as minutes per day) than
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TABLE 1 | Demographic and clinical characteristics for patients with schizophrenia and matched healthy controls.
Patients Controls
Characteristic (n = 63) (n = 55)
N (%) N (%) F p
Gender (male) 46 (73) 36 (65) 0.79 0.37
CASH: Schizophrenia 45 (71)
Schizo-affective disorder 15 (24)
Schizophreniform disorder 3 (5)
Marital status (single/married/divorced) 56/4/3 30/24/1 22.71 <0.001
Employment status (welfare/ working/ student/ unemployed/ unknown) 51/8/1/3/0 1/27/24/2/1 81.38 <0.001
Treatment (inpatient/ day hospital/ out-patients/ unknown) 9/20/33/1
Parental education levela: 6.79 0.34
Primary school or less 3(5) 1 (2)
Secondary school 37 (59) 24 (44)
College or university degree 21 (33) 30 (54)
Unknown 2 (3) 0
MetS (yes)b 22 (35) 9 (16) 5.22 0.04
Mean SD Mean SD F p
Age (year) 29.6 7.4 29.3 7.7 0.07 0.80
Height (cm) 177.9 9.2 178.2 10.1 0.03 0.86
Weight (kg) 83.0 19.2 76.3 14.3 4.51 0.04
BMI (kg/m2) 26.3 6.0 23.9 3.3 6.60 0.01
VO2peak (ml/min/kg) 31.6 9.9 35.9 5.5 7.92 <0.01
WAIS Total IQ 87.2 15.6 108.1 13.8 58.13 <0.001
Nr. of MetS-criteria metb 2.3 1.4 1.5 1.2 9.55 0.003
Waist circumference (cm) 93.4 16.0 85.4 11.2 9.60 0.002
Systolic blood pressure (mm/hg) 125.4 12.6 122.8 12.2 1.33 0.25
Diastolic blood pressure (mm/hg) 76.2 9.1 74.6 9.1 0.99 0.32
Tryglicerides (mmol/L) 1.5 1.0 0.9 0.5 16.91 <0.001
HDL-cholesterol (mmol/L) 1.0 0.3 1.3 0.3 24.44 <0.001
LDL-cholesterol (mmol/L) 3.3 1.0 2.9 0.8 6.06 0.02
Smoking (cigarettes/day) 11.8 10.5 0.9 4.3 52.03 <0.001
Alcohol usage (glasses/week) 3.6 6.9 5.0 5.2 1.50 0.23
PANSS total score 62.6 10.7
PANSS positive factor score 15.52 4.0
PANSS negative factor score 17.46 5.8
MADRS total score 15.16 8.4
Duration of illness (years) 6.6 5.8
Hospitalization until measurement (days) 193.7 265.3
HEQ dose (mg/day) 8.1 5.2
aSocioeconomic status, expressed as highest level of education of one of both parents according to Roick et al. (30).
bAssessed according to the International Diabetes Foundation criteria (26). CASH, Comprehensive Assessment of Schizophrenia and History; MetS, Metabolic Syndrome; BMI, Body
Mass Index; VO2peak, maximum rate of oxygen consumption; WAIS, Wechsler Adult Intelligence Scale; HDL, High-density lipoproteins; LDL, Low-density lipoproteins; PANSS, Positive
and Negative Syndrome Scale; MADRS, Montgomery and Åsberg Depression Rating Scale; HEQ, haloperidol equivalent. Significant differences at < 0.05 level are presented in bold.
controls. Patients had significantly poorer CRF than healthy
controls (p < 0.01). Controlling for gender, age, BMI, and
marital status did not change results. Controlling for WAIS
IQ led to non-significance for TEE only. However, controlling
for employment status led to non-significant differences in SB,
PA, and TEE and AEE, but not in lying down and sleeping
time. Bonferroni-correction for multiple testing did not influence
the conclusions.
Differences in SB and PA on Weekdays vs.
Weekend Days
Except for vigorous PA, patients and controls demonstrated
significantly more SB, significantly less time on MVPA and
moderate PA, had lower TEE and AEE, took fewer steps, and
spent more time lying down and sleeping during the weekend
compared to weekdays (Monday through Friday) (see Table 3).
After Bonferroni-correction for multiple testing participants still
Frontiers in Psychiatry | www.frontiersin.org 4 February 2019 | Volume 10 | Article 87
Scheewe et al. Physical Activity and Fitness in Schizophrenia
TABLE 2 | SB and PA in patients with schizophrenia and matched healthy controls, controlled for gender, age, and BMI influences.
Group Test statistic
Characteristic Patients (n = 62) Controls (n = 52)
Mean ± SD Mean ± SD F p
SB (<3 MET; min/day) 1303.6 ± 70.2 1254.1 ± 68.1 8.39 0.005*
MVPA (≥3 MET; min/day)1 136.4 ± 70.2 185.2 ± 68.6 8.39 0.005*
Moderate (3-6 MET; min/day)1,a 105.3 ± 72.1 152.1 ± 63.3 12.98 < 0.001*
Vigorous (>6 MET; min/day)1,a 10.5 ± 20.3 16.1 ± 26.6 2.10 0.15
Total energy expenditure (kcal/day)1 2897 ± 582 3036 ± 455 10.74 0.001*
Active energy expenditure (kcal/day)1,a 718 ± 595 965 ± 421 9.62 0.002*
Steps (steps/day)1 8040 ± 3072 8884 ± 2837 1.97 0.16
Lying down (hours/day)2 11.4 ± 2.1 8.6 ± 1.2 65.95 <0.0001*
Sleeping time (hours/day)2 9.2 ± 1.9 6.5 ± 1.0 68.63 <0.0001*
1Higher score indicates superior physical activity.
2Lower score indicates superior physical activity.
aEXP-values of logarithmically transformed and analyzed data are presented. Significant results are presented in bold, *significant after Bonferoni correction for multiple testing.
SB, sedentary behavior; PA, physical activity; BMI, body mass index; MET, metabolic equivalent; MVPA, moderate to vigorous physical activity.
took significantly fewer steps and spent more time lying down
and sleeping. No significant differences between the two 24-h
weekday assessments were found in either patients or controls
for any of the SB or PA variables (all p > 0.20). Whereas, no
differences in PA or energy expenditure were found between
Saturdays or Sundays in healthy controls, patients had lessMVPA
(p = 0.04) and lower TEE (p = 0.005), and AEE (p = 0.009) on
Saturdays compared to Sundays.
Associations of SB, MVPA, and CRF With
Mental and Physical Health
In patients, for mental health, a significant final model for SB
emerged [F(1, 59) = 4.46; p = 0.039; R2 = 0.069] in which PANSS
negative score (beta = 0.263; p = 0.039) was significantly
associated with SB. In the final model, gender, age, employment
status, WAIS IQ, PANSS positive, PANSS general, and MADRS-
score were not significantly associated with SB. This means that
increasing severity of negative symptoms was associated with
more SB. An identical but inversed model emerged for MVPA
which means that increasing severity of negative symptoms was
associated with fewer MVPA. For mental health, a significant
model for CRF emerged also [F(4, 56) = 17.195; p < 0.00000001;
R2 = 0.551] in which gender (female vs. male; beta = −0.398;
p < 0.0001), age (beta = −0.417; p < 0.0001), and PANSS
negative score (beta = −0.502; p < 0.00001) MADRS score
(beta = 0.198; p = 0.040) were significantly associated with
CRF level indicating female gender, higher age, and more severe
depressive and particularly negative symptoms were associated
with poorer CRF.
In patients, for physical health, no significant final model
for either SB nor MVPA emerged since none of the variables
(gender, age, employment status, BMI, haloperidol equivalent of
antipsychotic medication prescribed, and number met criteria
for the MetS) were significantly associated with SB or MVPA,
respectively. For physical health, a significant model for CRF
did emerge [F(4, 54) = 17.566; p < 0.00000001; R2 = 0.570] in
which gender (female vs. male; beta = −0.255; p = 0.011), age
(beta = −0.214; p = 0.032), employment status (beta = −2.04;
p = 0.032), and BMI (beta = −0.489; p < 0.00001) were
significantly associated with CRF level. This means female
gender, higher age, being unemployed or on welfare, and higher
BMI were associated with poorer CRF.When negative symptoms
and BMI were combined in one regression model with CRF, both
factors were equally related.
In healthy controls, a significant model emerged for MVPA
[F(7, 10) = 7.095; p= 0.002; R2 = 0.225] in which gender (female
vs. male, beta = 0.307; p = 0.02) and BMI (beta = −0.31,
p = 0.02) were significantly associated with MVPA. The
same holds for SB [F(7, 19) = 7.095; p = 0.002; R2 = 0.225;
with gender −0.307, p = 0.02 and BMI 0.32, p = 0.02
being significantly associated] and CRF [F(3, 48) = 18.101;
p< 0.00000001; R2 = 0.531, with again gender −0.638,
p < 0.0000001, employment status (beta = −0.210; p = 0.056),
and BMI −0.54, p < 0.0001 being significantly associated with
CRF]. Noteworthy, females tended to have more MVPA and
less SB, but poorer CRF. The latter corresponds with the model
in patients, in which also female gender and higher BMI were
associated with poorer CRF.
DISCUSSION
This study examined objectively measured PA and inactivity,
SB and CRF in patients with schizophrenia compared to
inactive healthy controls. Patients with schizophrenia performed
significantly less MVPA, moderate PA, more SB, had lower total
and active energy expenditure, spent more time per day lying
down and sleeping, and had poorer CRF compared to healthy
controls. The amount of MVPA, but more prominently CRF
level, was associated with the severity of negative symptoms in
patients with schizophrenia. Only CRF, and not SB orMVPA, was
associated with BMI.
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TABLE 3 | Differences between day of measurement (weekdays vs. weekend) within (day) and between groups (day × group; patients vs. controls).
Group
Characteristic Patients (n = 62) Controls (n = 52) Test statistic
Weekday Weekend Weekday Weekend Day Day × Group
Mean ± SD Mean ± SD Mean ± SD Mean ± SD F p F p
SB (<3 MET; min/day) 1296 ± 82 1318 ± 74 1249 ± 84 1263 ± 70 5.3 0.02 0.3 0.60
MVPA (≥3 MET; min/day)1 143.8 ± 82.2 121.6 ± 74.7 190.6 ± 84.0 174.6 ± 74.7 5.8 0.02 0.2 0.70
Moderate (3-6 MET; min/day)1 126.4 ± 75.7 106.5 ± 61.9 165.7 ± 71.2 152.6 ± 60.4 5.3 0.02 0.2 0.63
Vigorous (>6 MET; min/day)1 17.5 ± 16.6 15.2 ± 26.4 24.9 ± 23.5 21.9 ± 27.7 1.1 0.29 0.02 0.89
Total energy expenditure (kcal/day)1 2943 ± 634 2805 ± 621 3069 ± 522 2970 ± 475 6.5 0.01 0.2 0.67
Active energy expenditure (kcal/day)1 896 ± 546 745 ± 525 1055 ± 471 979 ± 432 4.8 0.03 0.5 0.47
Steps (steps/day)1 8565 ± 3522 6990 ± 3522 9104 ± 3251 8443 ± 3669 9.8 0.002* 1.6 0.20
Lying down (hours/day)2 11.1 ± 2.2 11.9 ± 3.3 8.1 ± 1.3 9.6 ± 2.3 17.0 <0.0001* 1.7 0.19
Sleeping time (hours/day)2 8.8 ± 2.1 9.8 ± 2.7 6.1 ± 0.9 7.3 ± 1.9 25.1 <0.0001* 0.2 0.62
1Higher score indicates superior physical activity.
2Lower score indicates superior physical activity.
SB, sedentary behavior; MET, metabolic equivalent; MVPA, moderate to vigorous physical activity. Significant results are presented in bold, *significant after Bonferoni correction for
multiple testing.
This study adds to current knowledge by being one of the
few to include CRF in studying the relationship between PA, SB
and cardiovascular disease, and, more importantly, by being the
only one to use the gold standard CPET in measuring CRF. CRF
indeed appeared independently related to cardio-metabolic risk,
more so than SB or PA. This has two implications; it stresses the
importance of taking CRF into account when assessing patients’
physical health status, and it implies that the implementation of
interventions aiming to increase CRF is of utmost importance
in tackling the alarming cardio-metabolic health of patients
with schizophrenia (31). Two previous intervention studies
showed this was feasible in patients with schizophrenia (32,
33). In the current study, we found an association between
CRF and severity of negative symptoms, which is in line with
previous research (34). The direction of this association is as
of yet not exactly known; it may seem conspicuous to think
negative symptoms lead to inactivity which in turn affects CRF
levels. There is however emerging evidence that a bidirectional
association may be possible as well. Two studies found evidence
of a direct relationship of CRF (35) on cognition and PANSS
symptomatology (36), respectively. In other areas, such as
depression and bipolar disorder, the effect of physical activity on
mood has been widely established, even though the mechanisms
through which physical activity and brain functioning (mood,
cognition and symptoms) affect each other are not completely
understood yet. Nonetheless, this gives hope to the idea that
interventions aiming to increase CRF may also reduce negative
symptoms (37). This could, on its turn, have important functional
benefits as well since negative symptoms evidently impact an
individual’s functional capacity in daily activities (38).
Our results are furthermore consistent with previous studies
which reported lower levels of PA in patients with schizophrenia
compared to healthy comparison subjects (30, 39–44). In line
with earlier findings, we found patients with schizophrenia spend
less time on moderate PA, but not on vigorous PA (43). In
accordance with the only study that used doubly labeled water,
the established criterion standard method for free-living energy
expenditure assessment, we found reduced total and active
energy expenditure in patients with schizophrenia (45).
Some limitations should be considered when interpreting
present findings. First, SenseWear reliably assesses PA and energy
expenditure in normal and overweight healthy adults (21–23,
46), yet has not been validated in patients with schizophrenia.
SenseWear overestimated energy expenditure in obese subjects
(46) and the current study included 15 obese patients and 2 obese
healthy controls (BMI>30). Papazoglou et al. (46) used an older
software version than the present study which was later shown to
have an inferior accuracy (23). Second, as this is a cross-sectional
study, only relationships between SB, PA, and CRF, and mental
and physical health parameters could be examined, not causality.
Third, we did not succeed in enrolling healthy controls fully
matching the schizophrenia patient group, other than on age,
socio-economic status and inactivity. In terms of cardiometabolic
health, the patients were much worse off, which on the one hand
stresses the seriousness of their health condition, but on the other
hand impedes true comparison of the two groups. In addition,
patients with schizophrenia and healthy subjects volunteered
to engage in the study, which may have led to some selection
bias because subjects motivated for PA and health improvement
might have had greater interest in this study. Accordingly, this
may have led to an overestimation of activity levels compared
to the entire schizophrenia population. Also, the absence of a
matched psychiatric control group is a limitation of our study.
It would have been interesting to see whether activity patterns
and CRF levels of patients with schizophrenia differ from patients
with other psychiatric diagnoses. This might also shed light on
the role of negative symptoms, which may be present in patients
with other psychiatric disorders but are often more pronounced
in patients with schizophrenia. Fourth, one could argue that
the CPET is too strenuous for patients with schizophrenia. In
our study, however, all controls and all but four patients with
schizophrenia met maximal effort demand (RER peak ≥1.1),
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albeit that patients with schizophrenia did reach significantly
lower average RER peak values than controls. This could however
in part be due to poorer CRF and the fact that they are not
accustomed to perform high-intensity exercise. Last, others often
define SB as <1.5 MET whereas we defined it as <3 MET. This
may have led to a higher estimate of SB.
In conclusion, our study shows patients with schizophrenia
perform less PA, expend less total and active energy, spend
more time lying down and sleeping, and have poorer CRF
compared to physically inactive matched, healthy controls. Given
the remarkably strong associations of CRF with both negative
symptoms and BMI, improvement of CRF should be a primary
treatment aim, which may affect both mental and physical health
in patients with schizophrenia.
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